EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions

Joshua Burshtein, Todd Schlesinger

Journal of Drugs in Dermatology · 01.04.2026 · 25 (4) · 311-315

DOI: 10.36849/jdd.9613 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.03.2026. Verfasst von Joshua Burshtein und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Chronic Urticaria, Protein Kinase Inhibitors, Pyrimidines. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic UrticariaProtein Kinase InhibitorsPyrimidinesHumansAgammaglobulinaemia Tyrosine KinaseClinical Trials, Phase III as TopicTreatment Outcome

Substanzen

Agammaglobulinaemia Tyrosine KinaseProtein Kinase InhibitorsBTK protein, humanPyrimidinesremibrutinib

Zitieren

APA

Burshtein, J., & Schlesinger, T. (2026). Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions. Journal of Drugs in Dermatology, 25(4), 311-315. https://doi.org/10.36849/jdd.9613

Vancouver

Burshtein J, Schlesinger T. Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions. Journal of Drugs in Dermatology. 2026;25(4):311-315. doi:10.36849/jdd.9613

BibTeX
@article{Burshtein2026,
  author = {Burshtein, Joshua and Schlesinger, Todd},
  title = {Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions},
  journal = {Journal of Drugs in Dermatology},
  year = {2026},
  volume = {25},
  number = {4},
  pages = {311--315},
  doi = {10.36849/jdd.9613}
}
Kostenlos starten →